\
&
Contact us
\
&
Contact us
Activities under Cluster 6 will help to accelerate the ecological transition required by the European Green Deal in order to achieve climate neutrality by 2050. R&I activities will support the policy objectives of the EU biodiversity strategy for 2030, the circular economy action plan, the EU industrial strategy, the bio-economy strategy, the EU forest strategy, the blue growth strategy, the chemicals strategy for sustainability and the EU plastics strategy, in addition to the EU Climate policy. Cluster 6 will also steer and accelerate the transition to sustainable, healthy and inclusive food systems, to achieve effectively the objectives of the Farm to Fork Strategy.
These objectives are translated in seven destinations and impacts:
Areas of activity
As an integral part of Horizon Europe, a set of EU Missions aim to deliver solutions to some of the greatest challenges facing Europe. The mission on Ocean and Waters and the mission on Soils are two of the 5 official mission areas defined by the Commission highly related to Cluster 6.
fernanda.werneck@vlaio.be
+32 2 553 02 62
pascal.verheye@vlaio.be
+32 2 553 09 84
patrick.demolder@vlaio.be
+32 497 59 33 90
Find the contact info on the site of WEWIS
The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.
The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.
Health Civil Security Digital, Industry & Space Agro-Food, Environment
The European Innovation Council has launched a call to recruit independent experts of diverse innovative defence and dual-use technologies (as eg. maritime, medical, drones, financial expertise, ..). It is important for the EIC to have a solid batch of experts with a balanced national diversity. Note that, as a requirement and due to security sens... read more
Partnerships unite the EC and private and/or public partners to work together in a specific domain. They offer often a good ecosystem to find collaborations.
Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.
Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.
Documents contain additional information related to this programme, and are similar to related links.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
